COVID-19 (SARS-Cov-2) and the heart - An ominous association.
Citation: Cardiovascular Revascularization Medicine. 21(8):946-949, 2020 08.PMID: 32423791Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Case ReportsSubject headings: *Betacoronavirus | *Coronavirus Infections/co [Complications] | *Glucocorticoids/tu [Therapeutic Use] | *Myocarditis/et [Etiology] | *Pandemics | *Pneumonia, Viral/co [Complications] | *ST Elevation Myocardial Infarction/et [Etiology] | *Thrombolytic Therapy/mt [Methods] | Adult | Coronary Angiography | Coronavirus Infections/ep [Epidemiology] | Echocardiography | Electrocardiography | Female | Humans | Male | Middle Aged | Myocarditis/di [Diagnosis] | Myocarditis/dt [Drug Therapy] | Pneumonia, Viral/ep [Epidemiology] | ST Elevation Myocardial Infarction/di [Diagnosis] | ST Elevation Myocardial Infarction/dt [Drug Therapy]Year: 2020Local holdings: Available in print through MWHC library: 2002 - presentISSN:- 1878-0938
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 32423791 | Available | 32423791 |
Available in print through MWHC library: 2002 - present
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cardiovascular manifestations of COVID-19 are diverse and complex and include acute coronary syndrome, myocarditis masquerading as ST-segment elevation myocardial infarction, pericarditis and pericardial effusion. We present 2 cases of COVID-19 infection with myocardial involvement with distinct mechanistic pathways and outcomes. Important decision strategies such as the timing of cardiac catheterization (when indicated) and requirement of early hemodynamic support in critically ill patients are discussed. Copyright (c) 2020 Elsevier Inc. All rights reserved.
English